Literature DB >> 6439097

Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa.

L Galbraith, S G Wilkinson, N J Legakis, V Genimata, T A Katsorchis, E T Rietschel.   

Abstract

Comparative studies of a gentamicin-sensitive strain (P28-0) of Pseudomonas aeruginosa and a gentamicin-resistant mutant (P23-800) have been carried out. No aminoglycoside-modifying enzymes were detected in extracts of the mutant. Electron microscopy of thin sections and the loss of O-antigenicity suggested that resistance of the mutant to gentamicin was related to an alteration in the outer membrane. Analysis of the lipopolysaccharide (LPS) components of the cell walls revealed significant differences. The LPS from strain P28-0 was typical of wild-type P. aeruginosa strains of Habs serotype O6, with quinovosamine and aminogalacturonic acid as O-specific aminocomponents. The LPS from the resistant mutant lacked the O-specific polymer, but had a core oligosaccharide similar to that of the parent strain. Both LPS were rich in phosphorus, part of which was present in triphosphate residues. Although the 31P nuclear magnetic resonance spectra of the LPS differed in some respects, these differences did not seem to correlate with the disparity in sensitivity to gentamicin of the two organisms.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6439097     DOI: 10.1016/s0769-2609(84)80020-4

Source DB:  PubMed          Journal:  Ann Microbiol (Paris)        ISSN: 0300-5410


  8 in total

Review 1.  Aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  Keith Poole
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

2.  Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

Authors:  N J Legakis; L S Tzouvelekis; A Makris; H Kotsifaki
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  Cumulative effects of several nonenzymatic mechanisms on the resistance of Pseudomonas aeruginosa to aminoglycosides.

Authors:  Farid El'Garch; Katy Jeannot; Didier Hocquet; Catherine Llanes-Barakat; Patrick Plésiat
Journal:  Antimicrob Agents Chemother       Date:  2006-12-28       Impact factor: 5.191

4.  Epidemiology of community-acquired Pseudomonas aeruginosa infections in children.

Authors:  I Paraskaki; E Lebessi; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

5.  Polymyxin Susceptibility in Pseudomonas aeruginosa Linked to the MexXY-OprM Multidrug Efflux System.

Authors:  Keith Poole; Calvin Ho-Fung Lau; Christie Gilmour; Youai Hao; Joseph S Lam
Journal:  Antimicrob Agents Chemother       Date:  2015-09-14       Impact factor: 5.191

6.  Characterization of lipopolysaccharide-deficient mutants of Pseudomonas aeruginosa derived from serotypes O3, O5, and O6.

Authors:  T Dasgupta; T R de Kievit; H Masoud; E Altman; J C Richards; I Sadovskaya; D P Speert; J S Lam
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

7.  Evaluation of Synergistic Interactions Between Cell-Free Supernatant of Lactobacillus Strains and Amikacin and Genetamicin Against Pseudomonas aeruginosa.

Authors:  Sargol Aminnezhad; Rouha Kasra Kermanshahi; Reza Ranjbar
Journal:  Jundishapur J Microbiol       Date:  2015-04-18       Impact factor: 0.747

8.  Influence of Core Oligosaccharide of Lipopolysaccharide to Outer Membrane Behavior of Escherichia coli.

Authors:  Zhou Wang; Jianli Wang; Ge Ren; Ye Li; Xiaoyuan Wang
Journal:  Mar Drugs       Date:  2015-05-27       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.